These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12372514)

  • 21. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
    Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of anti-HIV-1 and anti-HSV-1 activities of 4H-[1,2,4]-triazolo[1,5-a]pyrimidin-5-one derivatives.
    Abdel-Hafez AA; Elsherief HA; Jo M; Kurokawa M; Shiraki K; Kawahata T; Otake T; Nakamura N; Hattori M
    Arzneimittelforschung; 2002; 52(11):833-9. PubMed ID: 12489255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
    Li X; Lu X; Chen W; Liu H; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2014 Oct; 22(19):5290-7. PubMed ID: 25150090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of the biotinylated anti-HIV compound BMMP and the target identification study.
    Kamo M; Tateishi H; Koga R; Okamoto Y; Otsuka M; Fujita M
    Bioorg Med Chem Lett; 2016 Jan; 26(1):43-5. PubMed ID: 26615887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Vince R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Boyer J; Arnoult E; Médebielle M; Guillemont J; Unge J; Jochmans D
    J Med Chem; 2011 Dec; 54(23):7974-85. PubMed ID: 22017513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
    Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
    Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitors.
    Ribone SR; Leen V; Madrid M; Dehaen W; Daelemans D; Pannecouque C; Briñón MC
    Eur J Med Chem; 2012 Dec; 58():485-92. PubMed ID: 23159806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lead optimization of diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Zeng ZS; Liang YH; Feng XQ; Chen FE; Pannecouque C; Balzarini J; De Clercq E
    ChemMedChem; 2010 Jun; 5(6):837-40. PubMed ID: 20333620
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel piperidinylpyrimidine derivatives as inhibitors of HIV-1 LTR activation.
    Fujiwara N; Nakajima T; Ueda Y; Fujita H; Kawakami H
    Bioorg Med Chem; 2008 Nov; 16(22):9804-16. PubMed ID: 18926711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.
    Mugnaini C; Alongi M; Togninelli A; Gevariya H; Brizzi A; Manetti F; Bernardini C; Angeli L; Tafi A; Bellucci L; Corelli F; Massa S; Maga G; Samuele A; Facchini M; Clotet-Codina I; Armand-Ugón M; Esté JA; Botta M
    J Med Chem; 2007 Dec; 50(26):6580-95. PubMed ID: 18052319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of 2-pyridinylpyrimidines as inhibitors of HIV-1 structural protein assembly.
    Kožíšek M; Štěpánek O; Parkan K; Berenguer Albiñana C; Pávová M; Weber J; Krӓusslich HG; Konvalinka J; Machara A
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3487-90. PubMed ID: 27353536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel family of diarylpyrimidines (DAPYs) featuring a diatomic linker: Design, synthesis and anti-HIV activities.
    Gu SX; Qiao H; Zhu YY; Shu QC; Liu H; Ju XL; De Clercq E; Balzarini J; Pannecouque C
    Bioorg Med Chem; 2015 Oct; 23(20):6587-93. PubMed ID: 26385446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
    Xue P; Lu HH; Zhu YY; Ju XL; Pannecouque C; Zheng XJ; Liu GY; Zhang XL; Gu SX
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1640-1643. PubMed ID: 28314598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.
    Manetti F; Esté JA; Clotet-Codina I; Armand-Ugón M; Maga G; Crespan E; Cancio R; Mugnaini C; Bernardini C; Togninelli A; Carmi C; Alongi M; Petricci E; Massa S; Corelli F; Botta M
    J Med Chem; 2005 Dec; 48(25):8000-8. PubMed ID: 16335924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrimidine sulfonylacetanilides with improved potency against key mutant viruses of HIV-1 by specific targeting of a highly conserved residue.
    Wan ZY; Yao J; Mao TQ; Wang XL; Wang HF; Chen WX; Yin H; Chen FE; De Clercq E; Daelemans D; Pannecouque C
    Eur J Med Chem; 2015 Sep; 102():215-22. PubMed ID: 26276435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Discovery and development of diarylpyrimidines (DAPYs) as next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
    Tian XT; Xie L
    Yao Xue Xue Bao; 2010 Feb; 45(2):177-83. PubMed ID: 21351427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Wan ZY; Yao J; Tao Y; Mao TQ; Wang XL; Lu YP; Wang HF; Yin H; Wu Y; Chen FE; De Clercq E; Daelemans D; Pannecouque C
    Eur J Med Chem; 2015 Jun; 97():1-9. PubMed ID: 25935383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of novel 2-arylalkylthio-4-amino-6-benzyl pyrimidines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Qin H; Liu C; Zhang J; Guo Y; Zhang S; Zhang Z; Wang X; Zhang L; Liu J
    Bioorg Med Chem Lett; 2010 May; 20(9):3003-5. PubMed ID: 20347295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.